Table 1.
Clinical characteristics of the study population.
| Sarcopenia | Nonsarcopenia | |
|---|---|---|
| Number | 158 | 336 |
| Male/female | 87/71 | 129/207 |
| Hyperuricemia (%) | 18.99% | 20.24% |
| Diabetes (%) | 74.05% | 80.4% |
| Hypertension (%) | 56.32% | 56.55% |
| ALT (U/L) | 22.85 ± 21.42 | 22.08 ± 16.77 |
| AST (U/L) | 23.14 ± 14.71 | 22.16 ± 15.44 |
| HbA1c | 7.79 ± 2.33 | 8.2 ± 2.36 |
| TC (mmol/L) | 4.38 ± 2.80 | 4.32 ± 1.53 |
| TG (mmol/L) | 1.50 ± 1.83 | 1.71 ± 1.65 |
| HDL (mmol/L) | 1.26 ± 0.39 | 1.21 ± 0.38 |
| LDL (mmol/L) | 2.47 ± 0.90 | 2.58 ± 0.97 |
| NAFLD (%) | 22.15%∗ | 37.20% |
| Excess hs-CRP (%) | 48.10%∗ | 30.95% |
| Age (years) | 73.75 ± 8.52∗ | 70.12 ± 6.95 |
| BMI (kg/m2) | 22.13 ± 2.97∗ | 25.02 ± 3.34 |
∗ P < 0.05.